ClinVar Miner

Submissions for variant NM_001039141.3(TRIOBP):c.2201C>T (p.Ser734Phe)

gnomAD frequency: 0.00069  dbSNP: rs199794705
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000334250 SCV000345415 uncertain significance not provided 2016-08-26 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001001791 SCV001159442 benign Autosomal recessive nonsyndromic hearing loss 28 2018-08-01 criteria provided, single submitter clinical testing
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital RCV001001791 SCV001984069 likely benign Autosomal recessive nonsyndromic hearing loss 28 2020-02-26 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000334250 SCV002412581 benign not provided 2023-12-31 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003323498 SCV004028843 uncertain significance not specified 2023-07-14 criteria provided, single submitter clinical testing Variant summary: TRIOBP c.2201C>T (p.Ser734Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00082 in 249556 control chromosomes in the gnomAD database, including 1 homozygotes. To our knowledge, no occurrence of c.2201C>T in individuals affected with Autosomal Recessive Nonsyndromic Hearing Loss 28 and no experimental evidence demonstrating its impact on protein function have been reported. Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as benign/likely benign (n=3) and VUS (n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly benign.
PreventionGenetics, part of Exact Sciences RCV003930190 SCV004745247 benign TRIOBP-related disorder 2019-10-29 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.